Boston Scientific loses bid for new patent trial in drug-treated stent case

DALLAS - A U.S. federal judge rejected a request by Boston Scientific Corp. for a new trial in a patent-infringement case that ended with a US$501-million judgment against the medical-device maker. Boston Scientific said it planned to appeal the ruling Wednesday by U.S....More